A detailed history of Callan Capital, LLC transactions in Danaher Corp stock. As of the latest transaction made, Callan Capital, LLC holds 1,588 shares of DHR stock, worth $374,513. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,588
Previous 3,358 52.71%
Holding current value
$374,513
Previous $838,000 47.37%
% of portfolio
0.03%
Previous 0.07%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$239.25 - $280.76 $423,472 - $496,945
-1,770 Reduced 52.71%
1,588 $441,000
Q2 2024

Aug 12, 2024

BUY
$235.51 - $267.98 $552,741 - $628,949
2,347 Added 232.15%
3,358 $838,000
Q1 2024

Oct 22, 2024

SELL
$224.58 - $256.19 $527,089 - $601,277
-2,347 Reduced 69.89%
1,011 $252,000
Q1 2024

May 03, 2024

BUY
$224.58 - $256.19 $227,050 - $259,008
1,011 New
1,011 $252,000
Q1 2022

May 10, 2022

SELL
$257.27 - $315.76 $157,449 - $193,245
-612 Closed
0 $0
Q4 2021

Jan 21, 2022

BUY
$292.08 - $329.01 $178,752 - $201,354
612 New
612 $202,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $172B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Callan Capital, LLC Portfolio

Follow Callan Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Callan Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Callan Capital, LLC with notifications on news.